Please login to the form below

Not currently logged in
Email:
Password:

Boyds expands regulatory affairs team

Céline Courtay-Cahen joins the pharma and biotech consultancy

Boyd Consultants Celine Courtay-CahenBoyd Consultants has appointed Céline Courtay-Cahen as a regulatory affairs consultant, based out of its Cambridge, UK office.

In her new role, Courtay-Cahen will manage projects including orphan drug designations, clinical trial applications and marketing authorisation applications.

She joins the consultancy from Evigo Pharma Consulting, where she also served as a regulatory affairs consultant and worked on a number of gene therapy projects, paediatric products, and in pharmacovigilance.

Prior to this, Courtay-Cahen worked in a various research positions with roles at the Institute of Structural Biology in Grenoble, the faculty of medicine at the Free University of Brussels, and the department of pathology at the University of Cambridge.

Alan Boyd, founder and chief executive officer of Boyd Consultants, said: “I am delighted to welcome Céline to our team at this exciting time. Her expertise will complement that of the team adding more value to our clients.”

17th June 2016

From: Regulatory

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Partnering with Patients and Caregivers in Clinical Research
...
Practical advice for Early Scientific Advice (ESA) in HTA submissions
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence...
Jonathan Cooke
The fight against antimicrobial resistance
By Jonathan Cooke...